Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
| ▸ | YARS1 | P54577 | 2/20 | 0.47 |
| ▸ | MME | P08473 | 2/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.45 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23598458 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL9665005 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL4434130 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL9664998 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| Hydrochloric Acid SCHEMBL20335514 | 0.99 | SLC7A5 (0.47) | SLC7A5YARS1MMEACECPA1 | |
| Hydrochloric Acid SCHEMBL924823 | 0.99 | SLC7A5 (0.47) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL31553196 | 0.98 | YARS1 (0.46) | SLC7A5YARS1MMEOPRM1OPRD1 | |
| SCHEMBL31259944 | 0.97 | MME (0.47) | SLC7A5YARS1MMEACEOPRM1 | |
| SCHEMBL31006409 | 0.97 | MME (0.47) | SLC7A5YARS1MMEACEOPRM1 | |
| SCHEMBL38650869 | 0.97 | MME (0.47) | SLC7A5YARS1MMEACEOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119931966-A | BsBacD enzyme mutant, enzyme composition and preparation method of tyrosine dipeptide | 深圳瑞德林生物技术有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2020071258-A1 | PROTEIN GLYCATION SUPPRESSANT | 味の素株式会社 | 2020-04-09 | — | — | WO | disclosed |
| US-20140343865-A1 | Biomarkers for Kidney Cancer and Methods Using the Same | METABOLON, INC. | 2014-11-20 | — | — | US | disclosed |
| EP-2788763-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013086365-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-2120846-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008107347-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (CH) | 2008-09-12 | — | — | WO | disclosed |
| EP-0132392-B1 | ASYMMETRIC SYNTHESIS OF ALPHA-SUBSTITUTED-ALPHA-CYANOMETHYL ALCOHOLS | ICI AUSTRALIA LIMITED (AU) | 1992-01-02 | — | — | EP | disclosed |
| EP-0304954-A2 | Cyclic dipeptide enantiomers | ICI AUSTRALIA LIMITED (AU) | 1989-03-01 | — | — | EP | disclosed |
| EP-0132392-A2 | Asymmetric synthesis of alpha-substituted-alpha-cyanomethyl alcohols | ICI AUSTRALIA LIMITED (AU) | 1985-01-30 | — | — | EP | disclosed |